Cargando…
Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein
The pathogenesis of bipolar affective disorder is associated with immunological imbalances, a general pro-inflammatory status, neuroinflammation, and impaired white matter integrity. Myelin basic protein (MBP) is one of the major proteins in the myelin sheath of brain oligodendrocytes. For the first...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267049/ https://www.ncbi.nlm.nih.gov/pubmed/35806400 http://dx.doi.org/10.3390/ijms23137397 |
_version_ | 1784743620117528576 |
---|---|
author | Kamaeva, Daria A. Smirnova, Liudmila P. Vasilieva, Svetlana N. Kazantseva, Daria V. Vasilieva, Alisa R. Ivanova, Svetlana A. |
author_facet | Kamaeva, Daria A. Smirnova, Liudmila P. Vasilieva, Svetlana N. Kazantseva, Daria V. Vasilieva, Alisa R. Ivanova, Svetlana A. |
author_sort | Kamaeva, Daria A. |
collection | PubMed |
description | The pathogenesis of bipolar affective disorder is associated with immunological imbalances, a general pro-inflammatory status, neuroinflammation, and impaired white matter integrity. Myelin basic protein (MBP) is one of the major proteins in the myelin sheath of brain oligodendrocytes. For the first time, we have shown that IgGs isolated from sera of bipolar patients can effectively hydrolyze human myelin basic protein (MBP), unlike other test proteins. Several stringent criteria were applied to assign the studied activity to serum IgG. The level of MBP-hydrolyzing activity of IgG from patients with bipolar disorder was statistically significantly 1.6-folds higher than that of healthy individuals. This article presents a detailed characterization of the catalytic properties of MBP-hydrolyzing antibodies in bipolar disorder, including the substrate specificity, inhibitory analysis, pH dependence of hydrolysis, and kinetic parameters of IgG-dependent MBP hydrolysis, providing the heterogeneity of polyclonal MBP-hydrolyzing IgGs and their difference from canonical proteases. The ability of serum IgG to hydrolyze MBP in bipolar disorder may become an additional link between the processes of myelin damage and inflammation. |
format | Online Article Text |
id | pubmed-9267049 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92670492022-07-09 Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein Kamaeva, Daria A. Smirnova, Liudmila P. Vasilieva, Svetlana N. Kazantseva, Daria V. Vasilieva, Alisa R. Ivanova, Svetlana A. Int J Mol Sci Article The pathogenesis of bipolar affective disorder is associated with immunological imbalances, a general pro-inflammatory status, neuroinflammation, and impaired white matter integrity. Myelin basic protein (MBP) is one of the major proteins in the myelin sheath of brain oligodendrocytes. For the first time, we have shown that IgGs isolated from sera of bipolar patients can effectively hydrolyze human myelin basic protein (MBP), unlike other test proteins. Several stringent criteria were applied to assign the studied activity to serum IgG. The level of MBP-hydrolyzing activity of IgG from patients with bipolar disorder was statistically significantly 1.6-folds higher than that of healthy individuals. This article presents a detailed characterization of the catalytic properties of MBP-hydrolyzing antibodies in bipolar disorder, including the substrate specificity, inhibitory analysis, pH dependence of hydrolysis, and kinetic parameters of IgG-dependent MBP hydrolysis, providing the heterogeneity of polyclonal MBP-hydrolyzing IgGs and their difference from canonical proteases. The ability of serum IgG to hydrolyze MBP in bipolar disorder may become an additional link between the processes of myelin damage and inflammation. MDPI 2022-07-02 /pmc/articles/PMC9267049/ /pubmed/35806400 http://dx.doi.org/10.3390/ijms23137397 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kamaeva, Daria A. Smirnova, Liudmila P. Vasilieva, Svetlana N. Kazantseva, Daria V. Vasilieva, Alisa R. Ivanova, Svetlana A. Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein |
title | Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein |
title_full | Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein |
title_fullStr | Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein |
title_full_unstemmed | Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein |
title_short | Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein |
title_sort | catalytic antibodies in bipolar disorder: serum iggs hydrolyze myelin basic protein |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267049/ https://www.ncbi.nlm.nih.gov/pubmed/35806400 http://dx.doi.org/10.3390/ijms23137397 |
work_keys_str_mv | AT kamaevadariaa catalyticantibodiesinbipolardisorderserumiggshydrolyzemyelinbasicprotein AT smirnovaliudmilap catalyticantibodiesinbipolardisorderserumiggshydrolyzemyelinbasicprotein AT vasilievasvetlanan catalyticantibodiesinbipolardisorderserumiggshydrolyzemyelinbasicprotein AT kazantsevadariav catalyticantibodiesinbipolardisorderserumiggshydrolyzemyelinbasicprotein AT vasilievaalisar catalyticantibodiesinbipolardisorderserumiggshydrolyzemyelinbasicprotein AT ivanovasvetlanaa catalyticantibodiesinbipolardisorderserumiggshydrolyzemyelinbasicprotein |